Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 8/2015

01-08-2015 | Capsule Commentary

Capsule Commentary on Williams et al., Factors Underlying Quality Problems with Alcohol Screening Prompted by a Clinical Reminder in Primary Care: A Multisite Qualitative Study

Author: Sarah M. Bagley, MD

Published in: Journal of General Internal Medicine | Issue 8/2015

Login to get access

Excerpt

One in ten deaths in working adults in the United States can be attributed to alcohol use.1 One response to contain alcohol-related consequences is to implement population-based screening using a validated instrument of adults.2 In order to ensure the same accuracy of the screening instrument, it must be used exactly as studied; for example, if done verbally, the language should be verbatim. …
Literature
1.
Stahre M, Roeber J, Kanny D, Brewer RD, Zhang X. Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States. Prev Chron Dis. 2014;11:E109.
2.
Jonas DE, Garbutt JC, Amick HR, et al. Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2012;157(9):645–54.PubMedCrossRef
3.
Williams EC, et al. Factors Underlying Quality Problems with Alcohol Screening Prompted by a Clinical Reminder in Primary Care: A Multisite Qualitative Study. JGIM. 2015; doi:10.​1007/​s11606-015-3248-z
Metadata
Title
Capsule Commentary on Williams et al., Factors Underlying Quality Problems with Alcohol Screening Prompted by a Clinical Reminder in Primary Care: A Multisite Qualitative Study
Author
Sarah M. Bagley, MD
Publication date
01-08-2015
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 8/2015
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3301-y

Other articles of this Issue 8/2015

Journal of General Internal Medicine 8/2015 Go to the issue

Letter to the Editor

Measuring Burnout in Primary Care Staff

Editorial

Reducing Burnout in Primary Care: A Step Toward Solutions

Clinical Practice: Clinical Images

Dermatological Manifestations of Infective Endocarditis

Letter to the Editor

Pending Studies at Hospital Discharge

Original Research

Health Literacy as a Social Determinant of Health in Asian American Immigrants: Findings from a Population-Based Survey in California

Editorial

Overdoses in Patients on Opioids: Risks Associated with Mental Health Conditions and Their Treatment
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits